The store will not work correctly when cookies are disabled.
3,5-dibromocytisine
ID: ALA1084011
Cas Number: 31954-92-4
PubChem CID: 15519734
Max Phase: Preclinical
Molecular Formula: C11H12Br2N2O
Molecular Weight: 348.04
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Synonyms: 3,5-Dibromocytisine | 3,5-dibromocytisine|CHEMBL1084011|DTXSID401122106|BDBM50482168|31954-92-4|(1R,5S)-9,11-Dibromo-1,2,3,4,5,6-hexahydro-1,5-methano-8H-pyrido[1,2-a][1,5]diazocin-8-one
Canonical SMILES: O=c1c(Br)cc(Br)c2n1C[C@@H]1CNC[C@H]2C1
Standard InChI: InChI=1S/C11H12Br2N2O/c12-8-2-9(13)11(16)15-5-6-1-7(10(8)15)4-14-3-6/h2,6-7,14H,1,3-5H2/t6-,7+/m0/s1
Standard InChI Key: UIRFWXCFBPYLDL-NKWVEPMBSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
10.7121 -4.6097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7320 -5.4346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4570 -5.8283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1622 -5.3973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1388 -4.5746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4173 -4.1787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4769 -6.6532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8836 -5.7932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5295 -3.7245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5689 -4.5373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2744 -4.9431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0268 -5.8656 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
11.3917 -3.3526 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
14.2544 -4.1183 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8440 -4.1436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5889 -5.3621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1723 -5.9455 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
12.6305 -3.3467 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 2 0
4 8 1 0
8 16 1 0
5 15 1 0
15 9 1 0
16 10 1 0
15 10 1 0
16 11 1 0
2 12 1 0
6 13 1 0
9 14 1 0
11 14 1 0
15 18 1 6
16 17 1 6
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 348.04 | Molecular Weight (Monoisotopic): 345.9316 | AlogP: 2.08 | #Rotatable Bonds: ┄ |
Polar Surface Area: 34.03 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.82 | CX LogP: 1.22 | CX LogD: -1.14 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.78 | Np Likeness Score: 0.03 |
References
1. Abin-Carriquiry JA, Zunini MP, Cassels BK, Wonnacott S, Dajas F.. (2010) In silico characterization of cytisinoids docked into an acetylcholine binding protein., 20 (12): [PMID:20493692] [10.1016/j.bmcl.2010.04.092] |